Diagram displaying Neutralisation curves of four different monoclonal antibodies, versus four different variants of SARS-CoV2.
The figure has a title at the top: Fig. 1: Neutralization of the SARS-CoV-2 variants D614G, Alpha, Beta and Delta by therapeutic monoclonal antibodies.
From: Reduced sensitivity of SARS-CoV-2 varian Delta to antibody neutralization
There are then four graphs, side by side. From left to right, they are labelled Bamlaniximab, Etesivimab, Casrivimab and Imdevimab.
All four y-axis labels are Neutralization (%) and they all go up as follows: 0, 20, 40, 60, 80, 100, 120.
All four x-axis labels are Concentration (μg ml−1)
The key for the four lines are D614G, Alpha, Beta, Delta.
Below the graph is the following text: Neutralization curves of monoclonal antibodies. Dose-response analysis of neutralization of the D614Gstrain and the Alpha, Beta and Deltavariants by four therapeutic monoclonal antibodies (bamlanivimab, etesivimab, casirivimab and imdevimab). Data are mean ± sd. of four independent experiments.